The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
How long have we got? The accuracy of physicians’ estimates and scenarios for survival time in 898 women with recurrent ovarian cancer (ROC).
 
Felicia Roncolato
No Relationships to Disclose
 
Rachel O'Connell
No Relationships to Disclose
 
Florence Joly
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Pfizer; Roche; Sanofi; Tesaro
Research Funding - Astellas Pharma; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Roche; tesaro
 
Anne Lanceley
No Relationships to Disclose
 
Felix Hilpert
No Relationships to Disclose
 
Aikou Okamoto
No Relationships to Disclose
 
Eriko Aotani
No Relationships to Disclose
 
Sandro Pignata
No Relationships to Disclose
 
Paul P. Donnellan
No Relationships to Disclose
 
Amit M. Oza
Honoraria - Intas
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Elisabeth Avall-Lundqvist
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genmab; Tesaro
 
Jonathan S. Berek
Consulting or Advisory Role - Takeda
Research Funding - Tesaro (Inst)
 
Jalid Sehouli
Honoraria - AstraZeneca; Clovis Oncology; Eisai; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Merck; MSD Oncology; Pfizer; PharmaMar; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Jonathan A. Ledermann
Honoraria - AstraZeneca/MedImmune; Roche
Consulting or Advisory Role - Artios; AstraZeneca/MedImmune; Clovis Oncology; Cristal Therapeutics; Merck; Pfizer; Seagen; Tesaro
Speakers' Bureau - Clovis Oncology; Pfizer
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
 
Dominique Berton-Rigaud
No Relationships to Disclose
 
Belinda Emma Kiely
Honoraria - Novartis; Roche; Roche
Consulting or Advisory Role - Novartis; Roche; Roche; specialised therapeutics; Teva
Travel, Accommodations, Expenses - Roche
 
Michael Friedlander
Honoraria - AstraZeneca; Lilly; MSD; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Lilly; MSD; Takeda
Speakers' Bureau - AstraZeneca
Research Funding - BeiGene (Inst)
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Tilray (Inst)
Travel, Accommodations, Expenses - Medivation/Pfizer